课题基金 / 基金详情

Dynamics of Transforming Growth Factor Beta Receptors

Dynamics of Transforming Growth Factor Beta Receptors
转化生长因子β受体的动力学
批准号:
6519814
负责人:
EDWARD B LEOF
金额:
$25.4万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-05-01 至 2005-04-30

项目摘要

项目成果

EDWARD B LEOF的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): A central paradox in transforming growth factor beta (TGF-b) biology is how the same growth factor can induce such divergent responses as growth stimulation (e.g., mesenchymal cells) and growth inhibition (e.g., epithelial cells). Considering the pivotal role TGF-b has in a number of normal and pathological conditions, addressing that issue is fundamental if we hope to be able to develop specific intervention strategies. To that end, during the previous funding cycle we have determined that receptor elements and activity differentially regulate TGF-b receptor (TGF-bR) endocytosis depending upon the cell type. However, it is presently unclear how this endocytic response is coupled to receptor signaling and subsequently cellular phenotypes. Two polarized views state that (i)endocytosis is simply a means to dampen the response - all signaling is initiated and completed at the plasma membrane; or (ii) the endocytic system is required to promote the association of activated receptors with downstream signaling molecules. While these extreme viewpoints make for lively discussion, a more appropriate question would be: are these models mutually exclusive or is it possible to have aspects of each occurring in various cell types and/or receptor systems? In this competing renewal we wish to test the general hypothesis that the endocytosis and/or trafficking of TGF-bRs is controlled by defined receptor elements and regulates association with distinct signaling intermediaries in polarized and nonpolarized cells. Preliminary data is presented documenting specific association of TGFbRs with the b2 subunit ofAP2, a requirement for TGF-bR internalization in Smad2 phsosphorylation, and polarized TGF-bR trafficking and signaling. We will further extend this concept of an integrated action of the endocytic and signaling machineries in distinct cell types by (i) characterizing the interaction and functional significance of TGF-bRs with the plasma membrane AP2 complex in fibroblasts and epithelial cells; (ii) defining the relationship between TGF-bR endocytosis and signaling in various cell types; and (iii) identifying the receptor elements regulating basolateral TGF-bR sorting and determining whether this polarized membrane location differentially engages the signaling and endocytic machinery.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developmental Research Program
  • 批准号:
    10006089
  • 项目类别:
  • 资助金额:
    $9.06万
  • 财政年份:
    2018
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
CAF, A COACTIVATOR OF FOS, AND BREAST CANCER
  • 批准号:
    6124492
  • 项目类别:
  • 资助金额:
    $20.45万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
TGF BETA RECEPTOR DYNAMICS
  • 批准号:
    2024368
  • 项目类别:
  • 资助金额:
    $20.83万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
TGF BETA RECEPTOR DYNAMICS
  • 批准号:
    2701838
  • 项目类别:
  • 资助金额:
    $21.45万
  • 财政年份:
    1997
  • 负责人:
    EDWARD B LEOF
  • 依托单位:
国内基金
海外基金
通过Clathrin/AP2途径介导内皮细胞Occludin自噬性降解以靶向开放胶质瘤血肿瘤屏障的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    艾潇琳
  • 依托单位:
GRB2/Clathrin/ESCRT介导的内吞、运输及溶酶体降解在CD7 CAR-T细胞诱导T细胞CD7阴性表达的机制研究
  • 批准号:
    82270234
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    胡永仙
  • 依托单位:
TMEM30A通过Clathrin介导的囊泡转运参与足细胞损伤的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    彭雷
  • 依托单位:
活细胞高分辨率成像解析clathrin介导的内吞囊泡形成早期内体的分子机制